Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron E Katz

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Journal of Alternative and Complementary Medicine (New York, N.Y.)|March 5, 2003
Flavonoid and botanical approaches to prostate healthAaron E Katz
Nature Clinical Practice. Urology|January 30, 2008
Is salvage cryoablation effective in patients with prostate cancer who have failed radiation therapy?Aaron E Katz
BJU International|May 24, 2008
Focal treatment for low-risk prostate cancerAaron E Katz, Ravi Kacker
Integrative Cancer Therapies|July 1, 2010
ProstaCaid induces G2/M cell cycle arrest and apoptosis in human and mouse androgen-dependent and-independent prostate cancer cellsJun Yan, Aaron E Katz
Current Urology Reports|April 18, 2009
Update on cryotherapy for localized prostate cancerChad R Ritch, Aaron E Katz
Reviews in Urology|September 21, 2006
Selection of salvage cryotherapy patientsAaron E Katz, Mohamed A Ghafar
Current Urology Reports|July 9, 2017
Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature ReviewNicole M Golbari, Aaron E Katz
Urology Practice|August 10, 2023
Editorial CommentaryAndrew M Ho, Aaron E Katz
Current Oncology Reports|April 2, 2003
The current and potential role of cryoablation as a primary therapy for localized prostate cancerAaron E Katz, John C Rewcastle
European Urology|May 3, 2011
Words of wisdom. Re: Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: improved outcomes with stringent enrollment criteria. Miocinovic R, Jones JS, Pujara AC, Klein EA, Stephenson AJAaron E Katz, Jillian L Capodice
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Journal of Alternative and Complementary Medicine (New York, N.Y.)|March 5, 2003
Flavonoid and botanical approaches to prostate healthAaron E Katz
Nature Clinical Practice. Urology|January 30, 2008
Is salvage cryoablation effective in patients with prostate cancer who have failed radiation therapy?Aaron E Katz
BJU International|May 24, 2008
Focal treatment for low-risk prostate cancerAaron E Katz, Ravi Kacker
Integrative Cancer Therapies|July 1, 2010
ProstaCaid induces G2/M cell cycle arrest and apoptosis in human and mouse androgen-dependent and-independent prostate cancer cellsJun Yan, Aaron E Katz
Current Urology Reports|April 18, 2009
Update on cryotherapy for localized prostate cancerChad R Ritch, Aaron E Katz
Reviews in Urology|September 21, 2006
Selection of salvage cryotherapy patientsAaron E Katz, Mohamed A Ghafar
Current Urology Reports|July 9, 2017
Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature ReviewNicole M Golbari, Aaron E Katz
Urology Practice|August 10, 2023
Editorial CommentaryAndrew M Ho, Aaron E Katz
Current Oncology Reports|April 2, 2003
The current and potential role of cryoablation as a primary therapy for localized prostate cancerAaron E Katz, John C Rewcastle
European Urology|May 3, 2011
Words of wisdom. Re: Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: improved outcomes with stringent enrollment criteria. Miocinovic R, Jones JS, Pujara AC, Klein EA, Stephenson AJAaron E Katz, Jillian L Capodice
Pageof 8